KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Debt (2016 - 2025)

AbbVie (ABBV) has disclosed Total Debt for 14 consecutive years, with $61.4 billion as the latest value for Q4 2025.

  • Quarterly Total Debt fell 8.5% to $61.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.4 billion through Dec 2025, down 8.5% year-over-year, with the annual reading at $61.4 billion for FY2025, 8.5% down from the prior year.
  • Total Debt for Q4 2025 was $61.4 billion at AbbVie, down from $65.0 billion in the prior quarter.
  • The five-year high for Total Debt was $85.5 billion in Q1 2021, with the low at $55.8 billion in Q2 2023.
  • Average Total Debt over 5 years is $67.0 billion, with a median of $65.5 billion recorded in 2025.
  • Peak annual rise in Total Debt hit 35.13% in 2021, while the deepest fall reached 25.36% in 2021.
  • Over 5 years, Total Debt stood at $64.2 billion in 2021, then dropped by 1.45% to $63.3 billion in 2022, then fell by 6.14% to $59.4 billion in 2023, then rose by 13.07% to $67.1 billion in 2024, then dropped by 8.5% to $61.4 billion in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $61.4 billion, $65.0 billion, and $65.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.